Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker.

Ronner E, Boersma E, Akkerhuis KM, Harrington RA, Lincoff AM, Deckers JW, Karsch K, Kleiman NS, Vahanian A, Topol EJ, Califf RM, Simoons ML.

Eur Heart J. 2002 Feb;23(3):239-46.

PMID:
11792139
4.

The role of eptifibatide in patients undergoing percutaneous coronary intervention.

Zeymer U.

Expert Opin Pharmacother. 2007 Jun;8(8):1147-54. Review.

PMID:
17516878
5.

[The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].

Galli M, Maggioni AP, Vassanelli C, Tavazzi L.

Ital Heart J Suppl. 2000 Feb;1(2):202-11. Review. Italian.

PMID:
10731377
6.

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.

Lincoff AM, Califf RM, Topol EJ.

J Am Coll Cardiol. 2000 Apr;35(5):1103-15. Review.

7.

[Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].

Auer J, Berent R, Lassnig E, Weber T, Maurer E, Eber B.

Herz. 2003 Aug;28(5):393-403. Review. German.

PMID:
12928738
8.

Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.

Bosch X, Marrugat J, Sanchis J.

Cochrane Database Syst Rev. 2013 Nov 8;(11):CD002130. doi: 10.1002/14651858.CD002130.pub4. Review.

PMID:
24203004
9.

An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.

Adgey AA.

Eur Heart J. 1998 Apr;19 Suppl D:D10-21. Review.

PMID:
9597518
10.

Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.

Bosch X, Marrugat J, Sanchis J.

Cochrane Database Syst Rev. 2013 Oct 18;(10):CD002130. doi: 10.1002/14651858.CD002130.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;(11):CD002130.

PMID:
24136036
11.
13.
14.
15.
16.

Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.

Bosch X, Marrugat J, Sanchis J.

Cochrane Database Syst Rev. 2010 Sep 8;(9):CD002130. doi: 10.1002/14651858.CD002130.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;10:CD002130.

PMID:
20824831
17.

Eptifibatide in percutaneous coronary intervention. A review.

Dery JP, O'Shea JC, Tcheng JE.

Minerva Cardioangiol. 2002 Oct;50(5):531-46. Review.

PMID:
12384635
18.

Glycoprotein receptor inhibitors in the management of acute coronary syndromes.

Saint-Jacques H, Harrington AR.

Curr Cardiol Rep. 2002 Jul;4(4):301-12. Review.

PMID:
12052269
20.

Early invasive strategies for acute coronary syndromes.

Quinn MJ, Brener SJ.

Curr Cardiol Rep. 2002 Jul;4(4):334-40. Review.

PMID:
12052273

Supplemental Content

Support Center